Literature DB >> 621635

Physiological perfusion model for cephalosporin antibiotics I: Model selection based on blood drug concentrations.

D S Greene, R Quintiliani, C H Nightingale.   

Abstract

Various cephalosporins with different degrees of protein binding were administered to human volunteers. Blood samples were collected as a function of time and were assayed for drug content by a microbiological assay. A pharmacokinetic analysis of the data was performed using a two-compartment model with and without protein binding in the central compartment and a perfusion model. Both the two-compartment model without protein binding and the physiological perfusion model adequately described the blood levels of all three cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 621635     DOI: 10.1002/jps.2600670217

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

Review 1.  A review of the applications of physiologically based pharmacokinetic modeling.

Authors:  K J Himmelstein; R J Lutz
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

Review 2.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Mean residence time in peripheral tissue.

Authors:  P J McNamara; J C Fleishaker; T L Hayden
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

4.  Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.

Authors:  Kimberly Holt; Min Ye; Swati Nagar; Ken Korzekwa
Journal:  Drug Metab Dispos       Date:  2019-07-19       Impact factor: 3.922

5.  Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

6.  Pharmacokinetics of cefroxadin (CGP 9000) in man.

Authors:  A Gerardin; J B Lecaillon; J P Schoeller; G Humbert; J Guibert
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

7.  Ocular pharmacokinetic models of clonidine-3H hydrochloride.

Authors:  C H Chiang; R D Schoenwald
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

8.  Prediction of human bioavailability from human oral administration data and animal pharmacokinetic data without data from intravenous administration of drugs in humans.

Authors:  Haruo Imawaka; Kiyomi Ito; Yoshiaki Kitamura; Kiyoshi Sugiyama; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

9.  Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics.

Authors:  J C Fleishaker; P J McNamara
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

10.  A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis.

Authors:  J W S Cattrall; E Asín-Prieto; J Freeman; I F Trocóniz; A Kirby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-07       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.